.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Drug patents in 130+ countries

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Novartis
McKinsey
QuintilesIMS
US Department of Justice
UBS
Cerilliant
Cipla
McKesson
Citi
Baxter

Generated: September 24, 2017

DrugPatentWatch Database Preview

PAXIL Drug Profile

« Back to Dashboard

What is the patent landscape for Paxil, and what generic Paxil alternatives are available?

Paxil is a drug marketed by Apotex Technologies and is included in four NDAs. There are five patents protecting this drug and three Paragraph IV challenges.

This drug has one hundred and fifty-nine patent family members in forty countries.

The generic ingredient in PAXIL is paroxetine hydrochloride. There are thirty drug master file entries for this compound. Fifty-five suppliers are listed for this compound. Additional details are available on the paroxetine hydrochloride profile page.

Summary for Tradename: PAXIL

Patents:3
Applicants:1
NDAs:4
Suppliers / Packagers: see list2
Bulk Api Vendors: see list41
Clinical Trials: see list58
Patent Applications: see list729
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:PAXIL at DailyMed

Pharmacology for Tradename: PAXIL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Apotex Technologies
PAXIL
paroxetine hydrochloride
SUSPENSION;ORAL020710-001Jun 25, 1997ABRXYesYes► Subscribe► SubscribeY► Subscribe
Apotex Technologies
PAXIL
paroxetine hydrochloride
CAPSULE;ORAL020885-004Oct 9, 1998DISCNYesNo► Subscribe► SubscribeY► Subscribe
Apotex Technologies
PAXIL CR
paroxetine hydrochloride
TABLET, EXTENDED RELEASE;ORAL020936-002Feb 16, 1999ABRXYesNo► Subscribe► SubscribeY► Subscribe
Apotex Technologies
PAXIL
paroxetine hydrochloride
CAPSULE;ORAL020885-001Oct 9, 1998DISCNYesNo► Subscribe► SubscribeY► Subscribe
Apotex Technologies
PAXIL
paroxetine hydrochloride
TABLET;ORAL020031-003Dec 29, 1992ABRXYesNo► Subscribe► SubscribeY► Subscribe
Apotex Technologies
PAXIL
paroxetine hydrochloride
CAPSULE;ORAL020885-002Oct 9, 1998DISCNYesNo► Subscribe► SubscribeY► Subscribe
Apotex Technologies
PAXIL CR
paroxetine hydrochloride
TABLET, EXTENDED RELEASE;ORAL020936-001Feb 16, 1999ABRXYesNo► Subscribe► SubscribeY► Subscribe
Apotex Technologies
PAXIL
paroxetine hydrochloride
CAPSULE;ORAL020885-001Oct 9, 1998DISCNYesNo► Subscribe► SubscribeY► Subscribe
Apotex Technologies
PAXIL CR
paroxetine hydrochloride
TABLET, EXTENDED RELEASE;ORAL020936-001Feb 16, 1999ABRXYesNo► Subscribe► SubscribeY► Subscribe
Apotex Technologies
PAXIL CR
paroxetine hydrochloride
TABLET, EXTENDED RELEASE;ORAL020936-003Dec 6, 2000ABRXYesYes► Subscribe► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Patents for Tradename: PAXIL

Paragraph IV (Patent) Challenges for PAXIL

Drugname Dosage Strength RLD Submissiondate
paroxetine hydrochlorideExtended-release Tablets37.5 mgPaxil CR5/19/2009
paroxetine hydrochlorideExtended-release Tablets25 mgPaxil CR9/9/2005
paroxetine hydrochlorideOral Suspension10 mg/5 mLPaxil2/10/2005

International Patent Family for Tradename: PAXIL

Country Document Number Estimated Expiration
United Kingdom2339428► Subscribe
South Africa9902899► Subscribe
Italy1312540► Subscribe
Finland4209► Subscribe
Portugal102291► Subscribe
Slovenia1020464► Subscribe
Slovakia20242000► Subscribe
United Kingdom9928693► Subscribe
Hong Kong1037877► Subscribe
Australia2392899► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Healthtrust
Federal Trade Commission
Citi
Cantor Fitzgerald
UBS
Baxter
US Department of Justice
Dow
Mallinckrodt
Farmers Insurance

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot